Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 9/20 | 0.34 |
| ▸ | MMP9 | P14780 | 9/20 | 0.34 |
| ▸ | MMP14 | P50281 | 8/20 | 0.34 |
| ▸ | MMP3 | P08254 | 4/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MMP7 | P09237 | 3/20 | 0.32 |
| ▸ | MMP1 | P03956 | 2/20 | 0.32 |
| ▸ | MMP8 | P22894 | 2/20 | 0.32 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.32 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1402756 | 0.88 | MMP2 (0.39) | MMP2MMP9MMP14MMP3TDP1 | |
| SCHEMBL28476909 | 0.82 | CYP17A1 (0.40) | MMP2MMP9MMP14MMP3FFAR1 | |
| SCHEMBL1402783 | 0.82 | FFAR4 (0.38) | MMP2MMP9MMP14MMP3TDP1 | |
| SCHEMBL28405250 | 0.78 | TDP1 (0.50) | MMP2MMP9MMP14MMP3TDP1 | |
| SCHEMBL1402613 | 0.78 | LTA4H (0.44) | HPGD | |
| SCHEMBL21409497 | 0.78 | MMP2 (0.35) | MMP2MMP9MMP14MMP3TDP1 | |
| SCHEMBL2734738 | 0.78 | DRD2 (0.40) | MMP2MMP9MMP14MMP3MAPT | |
| SCHEMBL11849761 | 0.78 | LTA4H (0.45) | CYP1A2 | |
| SCHEMBL2734453 | 0.78 | TDP1 (0.53) | MMP2MMP9MMP14MMP3TDP1 | |
| SCHEMBL1403018 | 0.77 | SMN1; SMN2 (0.35) | MMP2MMP9MMP14MMP3TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104334601-A | Curing agent for anionic curable compound, curable composition, cured product, novel imidazole compound, and use thereof | NIPPON SYNTHETIC CHEM IND | 2015-02-04 | — | — | CN | disclosed |
| US-8431330-B2 | Surface-treating agent for pattern formation and pattern-forming method using the surface-treating agent | FUJIFILM CORPORATION (JP) | 2013-04-30 | — | — | US | disclosed |
| US-8431330-B2 | Surface-treating agent for pattern formation and pattern-forming method using the surface-treating agent | FUJIFILM CORPORATION (JP) | 2013-04-30 | — | — | US | disclosed |
| US-20120076991-A1 | SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT | FUJIFILM CORPORATION (JP) | 2012-03-29 | — | — | US | disclosed |
| US-20120076991-A1 | SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT | FUJIFILM CORPORATION (JP) | 2012-03-29 | — | — | US | disclosed |
| US-8088566-B2 | Photoresists; using compound containing an orgaooxygen or organosulfur compound | FUJIFILM CORPORATION (JP) | 2012-01-03 | — | — | US | disclosed |
| US-8088566-B2 | Photoresists; using compound containing an orgaooxygen or organosulfur compound | FUJIFILM CORPORATION (JP) | 2012-01-03 | — | — | US | disclosed |
| US-20080241742-A1 | SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT | FUJIFILM CORPORATION (JP) | 2008-10-02 | — | — | US | disclosed |
| US-20080241742-A1 | SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT | FUJIFILM CORPORATION (JP) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080241742-A1 | SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT | KRT18, FSCN1, SLC11A2 | MMP2 2960/4885MMP9 3237/4885MMP14 600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.